Literature DB >> 29369350

Identification and molecular docking study of novel angiotensin-converting enzyme inhibitory peptides from Salmo salar using in silico methods.

Zhipeng Yu1,2, Yang Chen1, Wenzhu Zhao1, Jianrong Li1, Jingbo Liu3, Feng Chen2,4.   

Abstract

BACKGROUND: In order to circumvent some challenges of the classical approach, the in silico method has been applied to the discovery of angiotensin-converting enzyme (ACE) inhibitory peptides from food proteins. In this study, some convenient and efficient in silico tools were utilized to identify novel ACE inhibitory peptides from Salmo salar.
RESULTS: Collagen from Salmo salar was digested in silico into hundreds of peptides. Results revealed that tetrapeptides PGAR and IGPR showed potent ACE inhibitory activity, with IC50 values of 0.598 ± 0.12 and 0.43 ± 0.09 mmol L-1 , respectively. The molecular docking result showed that PGAR and IGPR interact with ACE mostly via hydrogen bonds and attractive charge. Peptide IGPR interacts with Zn+ at the ACE active site, showing high inhibitory activity.
CONCLUSION: Interaction with Zn+ in ACE may lead to higher inhibitory activity of peptides, and Pi interactions may promote the effect of peptides on ACE. The in silico method can be an effective method to predict potent ACE inhibitory peptides from food proteins.
© 2018 Society of Chemical Industry. © 2018 Society of Chemical Industry.

Entities:  

Keywords:  ACE inhibitory peptides; collagen; in silico; molecular docking

Mesh:

Substances:

Year:  2018        PMID: 29369350     DOI: 10.1002/jsfa.8908

Source DB:  PubMed          Journal:  J Sci Food Agric        ISSN: 0022-5142            Impact factor:   3.638


  8 in total

1.  Screening cyclooxygenase-2 inhibitors from Allium sativum L. compounds: in silico approach.

Authors:  Morteza Sadeghi; Mehran Miroliaei; Fatemeh Fateminasab; Mohammad Moradi
Journal:  J Mol Model       Date:  2021-12-30       Impact factor: 1.810

2.  Three Novel ACE Inhibitory Peptides Isolated From Ginkgo biloba Seeds: Purification, Inhibitory Kinetic and Mechanism.

Authors:  Fei-Fei Ma; Hao Wang; Chao-Kun Wei; Kiran Thakur; Zhao-Jun Wei; Li Jiang
Journal:  Front Pharmacol       Date:  2019-01-15       Impact factor: 5.810

3.  Angiotensin Converting Enzyme (ACE)-Peptide Interactions: Inhibition Kinetics, In Silico Molecular Docking and Stability Study of Three Novel Peptides Generated from Palm Kernel Cake Proteins.

Authors:  Mohammad Zarei; Najib Bin Zainal Abidin; Shehu Muhammad Auwal; Shyan Yea Chay; Zaibunnisa Abdul Haiyee; Adi Md Sikin; Nazamid Saari
Journal:  Biomolecules       Date:  2019-10-04

4.  Whey-Derived Peptides Interactions with ACE by Molecular Docking as a Potential Predictive Tool of Natural ACE Inhibitors.

Authors:  Yara Chamata; Kimberly A Watson; Paula Jauregi
Journal:  Int J Mol Sci       Date:  2020-01-29       Impact factor: 5.923

Review 5.  Computational strategies for the discovery of biological functions of health foods, nutraceuticals and cosmeceuticals: a review.

Authors:  Laureano E Carpio; Yolanda Sanz; Rafael Gozalbes; Stephen J Barigye
Journal:  Mol Divers       Date:  2021-07-14       Impact factor: 3.364

6.  Identification and Molecular Docking Study of a Novel Angiotensin-I Converting Enzyme Inhibitory Peptide Derived from Enzymatic Hydrolysates of Cyclina sinensis.

Authors:  Fangmiao Yu; Zhuangwei Zhang; Liwang Luo; Junxiang Zhu; Fangfang Huang; Zuisu Yang; Yunping Tang; Guofang Ding
Journal:  Mar Drugs       Date:  2018-10-27       Impact factor: 5.118

7.  High Throughput Identification of Antihypertensive Peptides from Fish Proteome Datasets.

Authors:  Yunhai Yi; Yunyun Lv; Lijun Zhang; Jian Yang; Qiong Shi
Journal:  Mar Drugs       Date:  2018-10-02       Impact factor: 5.118

8.  Camel Hemorphins Exhibit a More Potent Angiotensin-I Converting Enzyme Inhibitory Activity than Other Mammalian Hemorphins: An In Silico and In Vitro Study.

Authors:  Amanat Ali; Seham Abdullah Rashed Alzeyoudi; Shamma Abdulla Almutawa; Alya Nasir Alnajjar; Yusra Al Dhaheri; Ranjit Vijayan
Journal:  Biomolecules       Date:  2020-03-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.